by Paulo Coelho
with a vision for building a world class contract manufacturing organization. This vision grew from years of seeing our client's frustration with unresponsive CMOs, rejected batches, regulatory issues and an overall lack of capacity to reliably manufacture drug product.
Initial funding was provided by a core group of investors from the health care field. A team of industry experts was assembled, and work began on designing both the facility and the advanced electronic manufacturing systems. Selkirk completed facility design and broke ground on this new facility in September 2020.